HOME >> MEDICINE >> NEWS
New tipifarnib (R115777) data in AML presented at American Society of Hematology Annual Meeting

San Diego, December 6, 2004 Data on tipifarnib (R115777), a compound under investigation by Johnson & Johnson Pharmaceutical Research & Development, L.L.C. for the treatment of elderly patients with newly diagnosed poor-risk acute myeloid leukemia (AML), were presented at the 46th annual meeting of the American Society of Hematology (ASH).

AML is a rapidly progressing form of leukemia, which, in elderly patients, often results in death within a few months of diagnosis. Although the number of cases of AML is difficult to track on a global scale, based on available information, it is estimated that more than 60,000 new cases will be diagnosed worldwide in 2004. This includes nearly 12,000 new cases in the U.S. alone. Approximately 65 percent of new cases are expected to occur in adults age 65 or over. AML is expected to claim an estimated 8,870 lives in the U.S. in 2004.

Tipifarnib was discovered and developed at Johnson & Johnson Pharmaceutical Research & Development. Administered orally, tipifarnib is believed to inhibit farnesyl transferase, an enzyme required for activation of multiple tumor-growth pathways.

The ASH meeting featured presentations of tipifarnib datasets in AML and other areas of research, including the following abstracts:

Saturday, December 4

  • Phase II study of tipifarnib in previously untreated, poor-risk, elderly AML patients. Abstract 874
  • Identification of molecular predictors of response to tipifarnib. Abstract 861
  • In-vitro cytotoxicity of tipifarnib in pediatric AML and acute lymphocytic leukemia samples. Abstract 1172

Monday, December 6

  • Two abstracts on pharmacoeconomic data related to AML in the elderly. Abstracts 3142 and 3154

Publication only

  • Fas antigen (CD 95) in clonogenic AML and in vitro sensitivity to tipifarnib. Abstract 4398


'"/>


6-Dec-2004


Page: 1

Related medicine news :

1. Updated adjuvant data presented at SABCS show 30 percent reduction in recurrence
2. Elderly cancer patients are significantly under-represented in cancer clinical trials
3. Original research presented at AAFP Annual Scientific Assembly
4. New Investigator Award presented at the 2004 AIUM Annual Convention
5. Womens health research findings presented by University of Pittsburgh scientists
6. Awards & fellowships presented in Hawaii
7. Latest research in allergic disease to be presented at the 2004 AAAAI Annual Meeting
8. New scientific advances in gastroenterology presented at colleges 68th annual meeting
9. Minority children: over- or underrepresented in medical research?
10. Pharmacokinetic data presented at ICAAC on investigational HIV protease inhibitor 433908 (908)
11. Latest child neurology practices and studies presented at daylong briefing

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/30/2021)... , ... March 29, 2021 , ... ... the 21st Century , A Virtual Workshop Presented by WCG FDAnews and Cerulean ... 4:30 pm EDT, https://wcg.swoogo.com/modern-sop-and-quality-systems , Are one’s SOPs written for the ...
(Date:3/30/2021)... ... March 29, 2021 , ... According to data released ... reproductive age (13-44) in need of publicly funded contraception live in counties impacted by ... Colorado’s 64 counties have lost some of their Title X resources. , The ...
(Date:3/30/2021)... ... March 29, 2021 , ... Health Literacy Innovations (HLI), a ... confusion due to low health literacy today announces a new partnership with the ... work with ACAP’s member Safety Net Health Plans, those that provide comprehensive health ...
(Date:3/30/2021)... ... ... Dr. Colin Campbell is proud to announce the 1 year anniversary in their new state ... internal medicine and is a primary care specialist who has been practicing for 23 years. ... keep South Jersey healthy one patient at a time. , “Over the past year, Dr. ...
(Date:3/30/2021)... ... March 30, 2021 , ... The COVID-19 ... and survivors; their families; and their caregivers. Crossroads4Hope is addressing the needs of ... emotional support system, MyGo2Support, which meets needs of people impacted by cancer, no ...
Breaking Medicine News(10 mins):
(Date:3/30/2021)... ... March 29, 2021 , ... The University of Texas Health Science Center ... San Antonio Multispecialty and Research Hospital, a destination center for research and treatment of ... In a nod to the COVID-19 pandemic, the ceremony was held virtually. , William ...
(Date:3/30/2021)... ... March 29, 2021 , ... Iora Health ... primary care, has partnered with Devoted Health , one of the fastest-growing ... across Maricopa County and provides seniors with the highest-quality care and experience possible, ...
(Date:3/30/2021)... CITY (PRWEB) , ... March 29, 2021 , ... ... has joined the Vaccine Credential Initiative (VCI), a group bringing together leading health ... record of vaccination status, based on open, interoperable standards. By joining the VCI ...
Breaking Medicine Technology:
Cached News: